Amylyx Pharmaceuticals, Inc. (AMLX)

CIK 1658551 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Amylyx Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 20261440001193125-26-389245
Sep 11, 20261440001193125-26-389244
Sep 11, 20261440001193125-26-389247
Sep 11, 20261440001193125-26-389246
Sep 11, 20261440001193125-26-389243
Sep 8, 20268-K0001193125-26-385331
Sep 2, 202640001193125-26-380152
Aug 20, 20268-K0001193125-26-359418
Aug 20, 2026424B50001193125-26-359416
Aug 20, 202640001193125-26-359677
Aug 20, 202640001193125-26-359679
Aug 20, 202640001193125-26-359676
Aug 20, 202640001193125-26-359675
Aug 20, 202640001193125-26-359678
Aug 18, 20268-K0001193125-26-354716
Aug 18, 20268-K0001193125-26-354793
Aug 18, 2026424B50001193125-26-355696
Aug 6, 20268-K0001193125-26-336670
Aug 6, 202610-Q0001193125-26-336682
Jul 13, 202640001193125-26-301996
Jul 9, 20261440001950047-26-006982
Jun 8, 202640001193125-26-261641
Jun 8, 202640001193125-26-261637
Jun 8, 202640001193125-26-261640
Jun 8, 202640001193125-26-261647